New provisional serovar (E10163) of Shigella boydii.

Journal of Clinical Microbiology
R J GrossB Rowe

Abstract

Eleven bacterial strains are described which give the biochemical reactions characteristic of the genus Shigella but do not belong to any of the established or provisional serovars. The strains are biochemically and serologically indistinguishable, and it is proposed that they be regarded as members of a new provisional serovar of Shigella boydii. Strain E10163 is designated as the test strain for this new serovar.

Citations

Apr 21, 2007·Journal of Medical Microbiology·Kaisar A TalukderDavid A Sack
May 19, 2007·Journal of Medical Microbiology·Francine GrimontPatrick A D Grimont
Dec 1, 1982·Journal of Clinical Microbiology·R J GrossB Rowe
Jan 1, 1985·Journal of Clinical Microbiology·H G Wathen-GradyG K Morris
Feb 1, 1985·Journal of Clinical Microbiology·M ShmilovitzS Levi
Nov 1, 1990·Journal of Clinical Microbiology·H G Wathen-GradyI K Wachsmuth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Related Papers

Journal of Clinical Microbiology
R J GrossB Rowe
Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Shigeru MatsushitaShiro Yamai
Journal of Clinical Microbiology
R J GrossA A Lindberg
Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases
S MatsushitaY Kudoh
© 2021 Meta ULC. All rights reserved